share_log

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

4：持股變動聲明-董事 Lewis-Hall Freda C
美股SEC公告 ·  04/25 05:06
牛牛AI助理已提取核心訊息
Conduit Pharmaceuticals Inc. (CDT.US) has reported a transaction involving Freda C Lewis-Hall, a key figure associated with the company. The transaction took place on April 22, 2024. However, the details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. The relationship of Lewis-Hall to the issuer was not specified in the announcement.
Conduit Pharmaceuticals Inc. (CDT.US) has reported a transaction involving Freda C Lewis-Hall, a key figure associated with the company. The transaction took place on April 22, 2024. However, the details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. The relationship of Lewis-Hall to the issuer was not specified in the announcement.
Conduit Pharmicals Inc.（CDT.US）報告了一筆涉及與該公司相關的關鍵人物弗雷達·劉易斯-霍爾的交易。該交易於 2024 年 4 月 22 日進行。但是，有關交易性質的細節，包括交易的股票數量、交易價格和由此產生的股權，尚未披露。公告中沒有具體說明劉易斯-霍爾與發行人的關係。
Conduit Pharmicals Inc.（CDT.US）報告了一筆涉及與該公司相關的關鍵人物弗雷達·劉易斯-霍爾的交易。該交易於 2024 年 4 月 22 日進行。但是，有關交易性質的細節，包括交易的股票數量、交易價格和由此產生的股權，尚未披露。公告中沒有具體說明劉易斯-霍爾與發行人的關係。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。